SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-006096
Filing Date
2018-05-02
Accepted
2018-05-01 17:35:29
Documents
13
Period of Report
2018-05-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30107
2 ex99-1.htm EX-99.1 9441
3 ex99-2.htm EX-99.2 967
4 ex99-1_001.jpg GRAPHIC 189050
5 ex99-1_002.jpg GRAPHIC 137298
6 ex99-1_003.jpg GRAPHIC 244265
7 ex99-1_004.jpg GRAPHIC 239118
8 ex99-1_005.jpg GRAPHIC 241476
9 ex99-1_006.jpg GRAPHIC 227920
10 ex99-1_007.jpg GRAPHIC 191115
11 ex99-1_008.jpg GRAPHIC 173618
12 ex99-1_009.jpg GRAPHIC 83097
13 ex99-2_001.jpg GRAPHIC 71567
  Complete submission text file 0001493152-18-006096.txt   2519794
Mailing Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067
Business Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067 866-443-4666
Hoverink Biotechnologies, Inc. (Filer) CIK: 0001586494 (see all company filings)

IRS No.: 463590875 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55055 | Film No.: 18796719
SIC: 2834 Pharmaceutical Preparations